Migraines affecting your life? This could mean you are eligible for a new research study on an investigational preventative migraine treatment. This study involves regularly taking the study treatment to assess it’s impact on the average number of migraine days you experience in a typical month.
Read detailsStatus: Currently Recruiting
Why not join sign up to our Research Register and we’ll keep you updated on any new studies we are running.
Join Now
Join our Research Register to find out about new clinical trials and we will keep you updated on any studies that might be suitable for you. Taking part in a clinical trial is much easier than you think.
You will usually receive generous payments for your time and travel. You will be making a significant difference to the health and well-being of many people now and in the future.
Upon arrival at CPS Research:
Please arrive alone if at all possible.
Please inform us and do not attend if you have any of the following:
Please do not hesitate to contact us on 0141 946 7888 if you have any questions.
CPS Research was established by and continues to be staffed by qualified GPs with solid foundations in general medicine, supported by experienced research physicians.
CPS Research has averaged over 10 clinical trials per year during our 30-year history. These include studies in the fields of cardiology, endocrinology, gastroenterology, gynaecology, orthopaedics, psychiatry, immunology, dermatology, and respiratory medicine.
You fill out one of our online surveys to see if you might be eligible to take part, and we’ll take your contact details.
One of our experienced research nurses will give you a call to ask you some more questions about you and your medical background to confirm your eligibility. They will also be able to give you further information about the trial and answer any questions you might have. The questionnaire also contains further general information relating to the study procedures, visits, timelines etc.
Once your suitability has been confirmed, you’ll be given an appointment to come see us at our clinic and the time to think about getting involved. It is important for us both to make sure that taking part is the right decision for you! Taking part in clinical research is completely voluntary, and you always have the right to discontinue at any time.
On your first visit to our clinic, we will get your written consent to participate. You will meet our nurses and doctors, and again have the chance to ask any more questions that you may have. We want you to be totally comfortable and understand everything that’s happening for the duration of the trial you’re taking part in.
This is where we keep an eye on everything while you take your allocated study treatment. This may or may not be an active medication or treatment, and usually, neither you nor our nurses or doctors know which. This is called a double-blind, and it is why these studies can produce valuable results. Your participation could take several months or longer, and usually involves periodic visits back to our clinic to see us.
You’ve done it! Once you’ve completed all the steps required in the study, you’ll come back one last time for a final check. After that, we all wait for the final results of the trial when it finishes. Often trials are running in different locations all over the world. If the treatment has been proven to work, you may find that it’s soon available for your doctor to prescribe or for purchase over-the-counter.
Everyone is required to have a temperature check as they enter the clinic.
Multiple hand sanitisation stations are located throughout the clinic. Frequent hand cleaning is followed by all of our staff.
All staff will be equipped with personal protective equipment to keep you and them as safe as possible.
Every consultation room and visiting area is deep cleaned between visits to ensure your safety.
Social distancing of 2M will be in effect at all times within the clinic.
Each clinical room is fitted with a 0.1 micron HEPA air filtration system which filters the air removing viral particles.